Home
Agno Pharma

Agno Pharma Market Share Analysis for June 2026

Join Agno Pharmaceuticals at CPhl - Japan.

Industry: N/A

Domainagnopharma.com

Year Founded2002

Employees201 - 500

Annual Revenue$25M - $50M

Agno Pharma

Agno Pharma (including company regionals)

agnopharma.com

See more website traffic and engagement information

Agno Pharma Revenue up to June 2026 is 25M - 50M

revenue generated by Agno Pharma top domains

Agno Pharma top domains revenue over 3 years

Revenue for Agno Pharma top domains

agnopharma.com25M - 50M

See more with Sales Intelligence

Total visits to Agno Pharma's top domains

Understand Agno Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

agnopharma.com22.6K

See more with Sales Intelligence

Avg. visit duration in Agno Pharma's top domains

Analyze Agno Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

agnopharma.com00:00:08

See more with Sales Intelligence

Avg. pageviews on Agno Pharma's top domains

See how Agno Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

agnopharma.com1.38

See more with Sales Intelligence

Agno Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Agno Pharma

These are the website technologies, by industry, used by Agno Pharma top domains

Audio Video Media (3)

HTTP Live Streaming (HLS)

Mobile (3)

Meta Viewport

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from Agno Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAgno Pharma expands offices in United States, Northern America, Americas.Agno is expanding its U.S. footprint, according to founder and CEO James Chen, PhD.

NewsAgno Pharma LLC partners with Particlesciences.Agno Pharma LLC look forward to working with PSI on its own projects while providing another drug formulation technology to offer to their customers. - Bruce L. Frank, PhD, President and Chief Scientific Officer, DelAQUA Pharmaceuticals

NewsActylis sells assets to Agno Pharma.Agno Pharma acquires Actylis's CDMO manufacturing asset, the legacy Cascade Chemistry business based in Eugene, Oregon, strengthening Agno's US cGMP API development and manufacturing capabilities.